Clinical and Prognostic Value of MicroRNA-198-5p and XIAP in Sinonasal Squamous Cell Carcinoma: A Retrospective Study

ORIGINAL ARTICLE
Danu Yudistira, Sagung Rai Indrasari, Camelia Herdini, Irianiwati Widodo, Didik Setyo Heriyanto, Agustian Winarno Putra

 
For citation: Yudistira D, Indrasari SR, Herdini C, Widodo I, Heriyanto DS, Putra AW. Clinical and Prognostic Value of MicroRNA-198-5p and XIAP in Sinonasal Squamous Cell Carcinoma: A Retrospective Study. International Journal of Biomedicine. 2025;15(3):490-494. doi:10.21103/Article15(3)_OA4
 
Originally published September 5, 2025

Abstract: 

Background: Sinonasal squamous cell carcinoma is a rare malignancy with a poor prognosis. This study explores the expression of microRNA-198 and X-linked inhibitor of apoptosis protein (XIAP), two molecules implicated in cancer progression, and analyzes their association with clinical features and survival outcomes in patients with sinonasal squamous cell carcinoma.
Materials and Methods: The outcomes of 31 sinonasal squamous cell carcinoma patients at Dr. Sardjito General Hospital, Yogyakarta, between 2017 and 2022 were retrospectively analyzed. Survival analysis was performed using Kaplan-Meier curves, and differences between survival curves were assessed using the log-rank test.
miR-198 and XIAP were both upregulated in sinonasal squamous cell carcinoma, with a positive correlation between their levels. However, their expressions showed no significant association with clinical features or survival outcomes, indicating limited prognostic value in this patient population.
Conclusions: Despite the upregulation of miR-198 and XIAP in sinonasal squamous cell carcinoma, their expression levels did not significantly impact patient survival or correlate with clinical features. These findings suggest that additional molecular factors are involved in the progression of sinonasal squamous cell carcinoma.

Keywords: 
microRNA-198 • XIAP • sinonasal squamous cell carcinoma • prognosis factor • expression level
References: 
  1. Kawaguchi M, Kato H, Tomita H, Mizuta K, Aoki M, Hara A, Matsuo M. Imaging Characteristics of Malignant Sinonasal Tumors. J Clin Med. 2017 Dec 6;6(12):116. doi: 10.3390/jcm6120116. PMID: 29211048; PMCID: PMC5742805.
  2. Dutta R, Dubal PM, Svider PF, Liu JK, Baredes S, Eloy JA. Sinonasal malignancies: A population-based analysis of site-specific incidence and survival. Laryngoscope. 2015 Nov;125(11):2491-7. doi: 10.1002/lary.25465. Epub 2015 Jul 30. PMID: 26228792.
  3. Cracchiolo JR, Patel K, Migliacci JC, Morris LT, Ganly I, Roman BR, McBride SM, Tabar VS, Cohen MA. Factors associated with a primary surgical approach for sinonasal squamous cell carcinoma. J Surg Oncol. 2018 Mar;117(4):756-764. doi: 10.1002/jso.24923. Epub 2017 Nov 28. PMID: 29193098; PMCID: PMC5878715.
  4. Pérez-Escuredo J, Martínez JG, Vivanco B, Marcos CÁ, Suárez C, Llorente JL, Hermsen MA. Wood dust-related mutational profile of TP53 in intestinal-type sinonasal adenocarcinoma. Hum Pathol. 2012 Nov;43(11):1894-901. doi: 10.1016/j.humpath.2012.01.016. Epub 2012 May 8. PMID: 22575263.
  5. Comiati V, Scapellato ML, Alexandre E, Volo T, Borsetto D, Carrieri M, Emanuelli E, Cazzador D. Sinonasal cancer in a worker exposed to chromium in an unusual industrial sector. Med Lav. 2017 Dec 14;108(6):477-481. doi: 10.23749/mdl.v108i6.6606. PMID: 29240044.
  6. Mensi C, Consonni D, Sieno C, De Matteis S, Riboldi L, Bertazzi PA. Sinonasal cancer and occupational exposure in a population-based registry. Int J Otolaryngol. 2013;2013:672621. doi: 10.1155/2013/672621. Epub 2013 Sep 4. PMID: 24082884; PMCID: PMC3777129.
  7. Kılıç S, Kılıç SS, Kim ES, Baredes S, Mahmoud O, Gray ST, Eloy JA. Significance of human papillomavirus positivity in sinonasal squamous cell carcinoma. Int Forum Allergy Rhinol. 2017 Oct;7(10):980-989. doi: 10.1002/alr.21996. Epub 2017 Aug 31. PMID: 28859244.
  8. Thompson L. World Health Organization classification of tumours: pathology and genetics of head and neck tumours. Ear Nose Throat J. 2006 Feb;85(2):74. PMID: 16579185.
  9. Berindan-Neagoe I, Monroig Pdel C, Pasculli B, Calin GA. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin. 2014 Sep-Oct;64(5):311-36. doi: 10.3322/caac.21244. Epub 2014 Aug 7. PMID: 25104502; PMCID: PMC4461198.
  10. Yang J, Zhao H, Xin Y, Fan L. MicroRNA-198 inhibits proliferation and induces apoptosis of lung cancer cells via targeting FGFR1. J Cell Biochem. 2014 May;115(5):987-95. doi: 10.1002/jcb.24742. Retraction in: J Cell Biochem. 2024 Oct;125(10):e30547. doi: 10.1002/jcb.30547. PMID: 24357456.
  11. Wang M, Wang J, Kong X, Chen H, Wang Y, Qin M, Lin Y, Chen H, Xu J, Hong J, Chen YX, Zou W, Fang JY. MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8. Sci Rep. 2014 Sep 1;4:6145. doi: 10.1038/srep06145. PMID: 25174450; PMCID: PMC5385833.
  12. Tan S, Li R, Ding K, Lobie PE, Zhu T. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway. FEBS Lett. 2011 Jul 21;585(14):2229-34. doi: 10.1016/j.febslet.2011.05.042. Epub 2011 Jun 7. PMID: 21658389.
  13. Marin-Muller C, Li D, Bharadwaj U, Li M, Chen C, Hodges SE, Fisher WE, Mo Q, Hung MC, Yao Q. A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Clin Cancer Res. 2013 Nov 1;19(21):5901-13. doi: 10.1158/1078-0432.CCR-12-3776. Epub 2013 Aug 29. PMID: 23989979; PMCID: PMC3920728.
  14. Shen J, DiCioccio R, Odunsi K, Lele SB, Zhao H. Novel genetic variants in miR-191 gene and familial ovarian cancer. BMC Cancer. 2010 Feb 18;10:47. doi: 10.1186/1471-2407-10-47. PMID: 20167074; PMCID: PMC2831822.
  15. Cui Z, Zheng X, Kong D. Decreased miR-198 expression and its prognostic significance in human gastric cancer. World J Surg Oncol. 2016 Feb 6;14:33. doi: 10.1186/s12957-016-0784-x. PMID: 26852230; PMCID: PMC4744396.
  16. Ye L, Li S, Ye D, Yang D, Yue F, Guo Y, Chen X, Chen F, Zhang J, Song X. Livin expression may be regulated by miR-198 in human prostate cancer cell lines. Eur J Cancer. 2013 Feb;49(3):734-40. doi: 10.1016/j.ejca.2012.08.029. Epub 2012 Oct 13. PMID: 23069480.
  17. Zhao JJ, Yang J, Lin J, Yao N, Zhu Y, Zheng J, Xu J, Cheng JQ, Lin JY, Ma X. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst. 2009 Jan;25(1):13-20. doi: 10.1007/s00381-008-0701-x. Epub 2008 Sep 26. PMID: 18818933.
  18. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res. 2008 May 1;14(9):2588-92. doi: 10.1158/1078-0432.CCR-07-0666. PMID: 18451220.
  19. Paczkowska J, Szyfter K, Giefing M, Wierzbicka M. Genetic signature and profiling of head and neck cancer: where do we stand? Curr Opin Otolaryngol Head Neck Surg. 2017 Apr;25(2):154-158. doi: 10.1097/MOO.0000000000000348. PMID: 28141602.
  20. Nachmias B, Ashhab Y, Ben-Yehuda D. The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol. 2004 Aug;14(4):231-43. doi: 10.1016/j.semcancer.2004.04.002. PMID: 15219616.
  21. Hofmann HS, Simm A, Hammer A, Silber RE, Bartling B. Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer. J Cancer Res Clin Oncol. 2002 Oct;128(10):554-60. doi: 10.1007/s00432-002-0364-z. Epub 2002 Sep 5. PMID: 12384799.
  22. Tamm I, Kornblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, Andreeff M, Reed JC. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res. 2000 May;6(5):1796-803. PMID: 10815900.

Download Article
Received April 29, 2025.
Accepted June 12, 2025.
©2025 International Medical Research and Development Corporation.